Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
286 studies found for:    microspheres
Show Display Options
Rank Status Study
1 Completed Radioactive Holmium Microspheres for the Treatment of Liver Metastases
Conditions: Liver Metastasis;   Liver Tumors
Interventions: Device: holmium-166 poly lactic acid microspheres;   Device: holmium 166 microspheres
2 Recruiting Feasibility of Holmium-166 Micro Brachytherapy in Head and Neck Tumors
Conditions: Radioisotopes;   Head and Neck Neoplasms
Intervention: Device: Holmium-166 (poly L lactic acid) microspheres
3 Terminated A Study of Yttrium-90 Radioactive Resin Microspheres to Treat Colorectal Adenocarcinoma Metastatic to the Liver
Conditions: Colorectal Neoplasms;   Liver Neoplasms
Intervention: Device: Yttrium-90 Radioactive Resin Microspheres
4 Completed
Has Results
Study Of Intrahepatic Arterial Injection of 90-Y Glass Microspheres for Cholangiocarcinoma
Condition: Cholangiocarcinoma
Intervention: Device: TheraSphere® Yttrium-90 (Y-90) Microspheres
5 Completed Radioactive Holmium Microspheres for the Treatment of Unresectable Liver Metastases
Condition: Liver Neoplasms
Intervention: Device: Holmium-166 polylactic microspheres
6 Not yet recruiting STOPPER CHINA:With Tandem Microspheres in the Treatment of Localized Hepatocellular Carcinoma
Condition: Localized Hepatocellular Carcinoma
Intervention: Device: Tandem Microsphere loaded with Epirubicin
7 Terminated
Has Results
Yttrium-90 Radioembolization With Glass Microspheres (TheraSphere) for Patients With Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Intervention: Device: Selective internal radiation therapy of the liver with Yttrium-90 glass microspheres (TheraSphere)
8 Completed Clinical Study Examining the Safety and Efficacy of Doxorubicin Drug Eluting Microspheres Transarterial Embolization in the Setting of Hepatocellular Carcinoma (HCC)
Condition: Hepatocellular Carcinoma
Intervention: Drug: doxorubicin, superabsorbent polymer microspheres, embolotherapy
9 Completed Azithromycin Microspheres in Patients With Low Risk Community Acquired Pneumonia
Condition: Community-Acquired Pneumonia
Intervention: Drug: Azithromycin microspheres 2.0 single dose
10 Recruiting Embozene® Microspheres for Prostatic Arterial Embolization in Patients With Symptomatic Benign Prostatic Hyperplasia
Condition: Benign Prostatic Hyperplasia
Intervention: Drug: Embozene Microspheres
11 Recruiting Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Who Are Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres
Conditions: Neuroendocrine Tumors;   Gastrointestinal Neoplasms;   Carcinoid Tumors
Interventions: Drug: Lanreotide;   Device: Y-90 microspheres
12 Recruiting CIRSE Registry for LifePearl Microspheres
Conditions: Colorectal Carcinoma;   Neoplasm Metastasis
Intervention: Device: LifePearl Microspheres loaded with Irinotecan
13 Recruiting Tas-102 and Radioembolization With 90Y Resin Microspheres for Chemo-refractory Colorectal Liver Metastases
Conditions: Colon Cancer;   Rectal Cancer;   Liver Metastases
Interventions: Drug: Tas-102;   Device: SIR-Sphere
14 Completed Traditional (Traditional Chemoembolization) TACE Versus Microsphere TACE
Condition: Carcinoma, Hepatocellular
Interventions: Procedure: Selective TACE via microsphere loaded with Doxorubicin;   Procedure: Selective traditional TACE
15 Completed FOLFOX Plus SIR-SPHERES MICROSPHERES Versus FOLFOX Alone in Patients With Liver Mets From Primary Colorectal Cancer
Conditions: Colorectal Cancer;   Colorectal Carcinoma;   Liver Metastases
Interventions: Drug: Systemic chemotherapy (FOLFOX);   Device: SIR-Spheres yttrium-90 microspheres
16 Active, not recruiting A Pilot Study of "OncozeneTM" Microspheres for Intra-arterial Delivery of Doxorubicin
Condition: Hepatocellular Cancer
Intervention: Device: Oncozene-DEB-TACE
17 Completed Radioembolization With Yttrium-90 Microspheres for Intermediate or Advanced Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma;   Liver Cancer
Intervention: Device: Yttrium-90 microspheres (Therasphere MDS Nordion)
18 Completed SIR-Spheres® Microspheres Versus Transarterial Chemoembolisation in Patients With Unresectable Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Device: Radioembolisation (SIR-Spheres® microspheres);   Drug: Transarterial Chemoembolisation
19 Recruiting Predictive Value of β2-microspheres for Postoperative Delirium
Condition: Postoperative Delirium
Intervention:
20 Active, not recruiting Microparticle Enhanced Cytotoxic Transarterial Embolization Therapy
Condition: Colorectal Carcinoma
Intervention: Device: 40um Embozene TANDEM Microspheres

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.